Related Experiment Videos
[Principles of radiosynoviorthesis].
1Nuklearmedizinische Abteilung, Kantonsspital Basel.
Schweizerische Medizinische Wochenschrift
|May 5, 1990
Summary
Radiosynoviorthesis effectively treats rheumatoid arthritis by targeting affected joints with specific radionuclides. Early intervention yields the best outcomes, offering an alternative local therapy for rheumatoid patients.
Area of Science:
- Nuclear medicine
- Rheumatology
- Radiopharmaceutical therapy
Context:
- Rheumatoid arthritis (RA) is a chronic inflammatory disorder.
- Local treatment options for RA synovitis are crucial for joint preservation.
- Radiosynoviorthesis offers a targeted approach to managing RA joint inflammation.
Purpose:
- To evaluate the efficacy and application of radiosynoviorthesis in treating rheumatoid arthritis.
- To outline the radionuclide selection based on joint size for optimal therapeutic outcomes.
- To highlight factors influencing treatment success and potential side effects.
Summary:
- Radiosynoviorthesis utilizes beta-emitting radionuclides (90Y, 186Re, 169Er) tailored to joint size for treating chronic synovitis in rheumatoid arthritis.
- Synchronous corticosteroid injection minimizes side effects like irradiation synovitis.
- Approximately 60% of treated joints show good therapeutic results, with early treatment demonstrating higher success rates, particularly in ankle, knee, and shoulder joints.
Impact:
- Radiosynoviorthesis provides an effective alternative local therapy for rheumatoid arthritis patients.
- Early radiosynoviorthesis is most successful, especially for ankle, knee, and shoulder joints.
- This localized treatment can improve joint function and reduce inflammation in rheumatoid arthritis.